From Prescription to Transcription: Genome Sequence as Drug Target
- PMID: 26140587
- DOI: 10.1016/j.cell.2015.06.033
From Prescription to Transcription: Genome Sequence as Drug Target
Abstract
Personalizing treatments to account for genetically mediated differences in drug responses is an exciting opportunity to improve patient outcomes. In this issue, Soccio et al. reveal new mechanisms by which non-coding variants alter the activity of the anti-diabetic drug rosiglitazone.
Copyright © 2015 Elsevier Inc. All rights reserved.
Comment on
-
Genetic Variation Determines PPARγ Function and Anti-diabetic Drug Response In Vivo.Cell. 2015 Jul 2;162(1):33-44. doi: 10.1016/j.cell.2015.06.025. Cell. 2015. PMID: 26140591 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical